Clinical Trials Browser

Expanded_access × Recurrence × CNS × Clear all

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Neuroblastoma, Pancreatic Neoplasms, Recurrence

NCT01370330 2025-07-22

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

Available

CNS

Neoplasms, Neuroblastoma, Recurrence

NCT05592743 2024-11-05

Vorasidenib Expanded Access Program

Approved for marketing

CNS

Astrocytoma, Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Oligodendroglioma, Pathologic Processes, Recurrence, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Disease Attributes

NCT03015844 2024-07-05

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

Available

CNSEndocrine

Neuroblastoma, Pheochromocytoma, Recurrence

NCT01377532 2020-05-06

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

Approved for marketing

CNSEndocrine

Neoplasms, Paraganglioma, Pheochromocytoma, Recurrence

Clinical Trials

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

Vorasidenib Expanded Access Program

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma